MRC Technology Forms Alliance with World Leading Translational Research Centres
Monday, January 21, 2013
The aim of this alliance is to strengthen the international academic and/or not-for-profit drug development and commercialization network.
Cost of Drug Development Reduced Thanks to New Technology
Friday, January 18, 2013
De Montfort University (DMU) has come together with Ithaka Life Sciences Ltd to market new technology designed to speed up and reduce the cost of the development of new drugs and medicines.
BrainStorm Establishes Safety of Repeat Doses of NurOwn in Mice
Friday, January 11, 2013
Pre-clinical study conducted at GLP-compliant Harlan Laboratories.
British Pharmacological Society Honours Professor's World-Leading Research
Thursday, January 10, 2013
The Dean of Kingston University's Faculty of Science, Engineering and Computing has received a prestigious prize recognising her lifetime's work on drug metabolism.
In Vitro Study Finds Digested Formula, But Not Breast Milk, is Toxic to Cells
Wednesday, January 09, 2013
Findings may help explain development of fatal condition in premature infants.
GE Healthcare and Cellular Dynamics International Agree to Sublicense for Cellular Assay Patents
Wednesday, December 19, 2012
Companies have announced that GE Healthcare has licensed CDI to develop, manufacture and sell cellular assays and models derived from iPS cells for use in drug discovery and toxicity screening.
Optibrium and Digital Chemistry Announce Technology Collaboration
Friday, December 14, 2012
Integration of bioisostere database with automatic application and prioritisation will guide the identification of successful, novel, high quality compounds in drug discovery.
4SC Announces Positive Interim Results from Clinical Phase I/II SHORE Study
Thursday, December 13, 2012
Phase II part of study planned to start soon in 2013.
Lilly Provides Update on Next Steps for Solanezumab
Thursday, December 13, 2012
Eli Lilly and Company provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease.
|
|
|
|
|
|
